Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bostjan Seruga

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Should my accountant sing La Traviata at the Met?Bostjan Seruga, Malcolm Moore
Breast Cancer Research and Treatment|May 11, 2010
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysisBostjan Seruga, Eitan Amir
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Chemotherapy-based treatment for castration-resistant prostate cancerBostjan Seruga, Ian F Tannock
Radiology and Oncology|April 13, 2024
Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial managementMilena Blaz Kovac, Bostjan Seruga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Mathematics in the realm of lapatinib: 500 + 500 = 1,500?Bostjan Seruga, Ian F Tannock
Nature Clinical Practice. Oncology|July 17, 2008
Intermittent androgen blockade should be regarded as standard therapy in prostate cancerBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothesBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Clinical research: show us the dataAlberto Ocana, Eitan Amir, Bostjan Seruga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Multidimensional challenges in clinical drug development, regulatory approval, and marketingAlberto Ocana, Bostjan Seruga, Eitan Amir
Lancet (London, England)|February 24, 2015
Pathological complete response in breast cancerAlberto Ocana, Bostjan Seruga, Eitan Amir
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Should my accountant sing La Traviata at the Met?Bostjan Seruga, Malcolm Moore
Breast Cancer Research and Treatment|May 11, 2010
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysisBostjan Seruga, Eitan Amir
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Chemotherapy-based treatment for castration-resistant prostate cancerBostjan Seruga, Ian F Tannock
Radiology and Oncology|April 13, 2024
Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial managementMilena Blaz Kovac, Bostjan Seruga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Mathematics in the realm of lapatinib: 500 + 500 = 1,500?Bostjan Seruga, Ian F Tannock
Nature Clinical Practice. Oncology|July 17, 2008
Intermittent androgen blockade should be regarded as standard therapy in prostate cancerBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothesBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Clinical research: show us the dataAlberto Ocana, Eitan Amir, Bostjan Seruga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Multidimensional challenges in clinical drug development, regulatory approval, and marketingAlberto Ocana, Bostjan Seruga, Eitan Amir
Lancet (London, England)|February 24, 2015
Pathological complete response in breast cancerAlberto Ocana, Bostjan Seruga, Eitan Amir
Pageof 9